Key result
Higher heart rate variability correlates inversely with tumor and neurodegenerative biomarkers in favorable-prognosis patients.
Why the study?
Mind-body debates assume better brain-body associations are healthy, leading researchers to examine whether associations between a vagal nerve index and peripheral disease biomarkers predict prognosis.
Does the degree of association between heart rate variability and peripheral disease biomarkers predict prognosis in patients with advanced pancreatic cancer or multiple sclerosis?
Observational (n=390)
Yes
Does the degree of association between heart rate variability and peripheral disease biomarkers predict prognosis in patients with advanced pancreatic cancer or multiple sclerosis?
Stronger inverse correlations between heart rate variability and peripheral disease biomarkers predict better prognosis in patients with advanced pancreatic cancer and multiple sclerosis.
Answers are grounded in this paper and cite their sources.
HRV-biomarker correlations may support prognostic assessment in pancreatic cancer and MS; hypothesis-generating and requires prospective validation.
‘Mind–body’ debates assume that better brain–body associations are healthy. This study examined whether degree of associations between a neurophysiological vagal nerve index and peripheral disease biomarkers predict prognosis in pancreatic cancer (PC) and multiple sclerosis (MS). Sample 1 included 272 patients with advanced PC. Sample 2 included 118 patients with MS. We measured the vagal nerve index heart rate variability (HRV) derived from electrocardiograms. We examined associations between HRV and patients’ peripheral disease biomarkers: CA19-9 in PC and neurofilament light chain (NFL) in MS. Associations between HRV and each biomarker were examined separately in patients who survived or died (PC), and in those with and without relapse during 12 months (MS). In PC, HRV was significantly inversely related to the tumor marker CA19-9 in patients who later survived (r = −0.44, p < 0.05) but not in those who died (r = 0.10, NS). In MS, HRV was significantly and inversely related to NFL only in those who did not relapse (r = −0.25, p < 0.05), but not in those who relapsed (r = −0.05, NS). The degree of association between a neurophysiological vagal marker and peripheral disease biomarkers has prognostic value in two distinct diseases.
No takes yet. Share an insight, caveat, or question.
Gidron et al. (2019) conducted an observational in Pancreatic cancer and multiple sclerosis (n=390). Heart rate variability (HRV) correlation with peripheral disease biomarkers (CA19-9 in pancreatic cancer; neurofilament light chain [NFL] in multiple sclerosis) vs. Patients with poor prognosis (death in pancreatic cancer or 12-month relapse in multiple sclerosis) was evaluated on Partial correlation between heart rate variability (SDNN) and peripheral disease biomarkers (CA19-9 in pancreatic cancer; NFL in multiple sclerosis) stratified by prognosis (r = -0.44 (PC survivors vs r = 0.10 in non-survivors); r = -0.25 (MS non-relapse vs r = -0.05 in relapse), p=<0.05). Heart rate variability inversely correlated with CA19-9 in surviving pancreatic cancer patients and with NFL in non-relapsing MS patients.
Synapse has enriched 10 related papers. Consider them for comparative context: